☰

Jason B. Garrison, Ph.D. - Publications

Affiliations: 
2007 University of Kentucky, Lexington, KY 
Area:
Biochemistry
Tree Info Similar researchers PubMed Report error

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Garrison JB, Ge C, Che L, Pullum DA, Peng G, Khan S, Ben-Jonathan N, Wang J, Du C. Knockdown of the Inhibitor of Apoptosis BRUCE Sensitizes Resistant Breast Cancer Cells to Chemotherapeutic Agents. Journal of Cancer Science & Therapy. 7: 121-126. PMID 26191375 DOI: 10.4172/1948-5956.1000335  0.331
2007 Garrison JB, Shaw YJ, Chen CS, Kyprianou N. Novel quinazoline-based compounds impair prostate tumorigenesis by targeting tumor vascularity. Cancer Research. 67: 11344-52. PMID 18056461 DOI: 10.1158/0008-5472.Can-07-1662  0.627
2006 Isaacs JT, Pili R, Qian DZ, Dalrymple SL, Garrison JB, Kyprianou N, Björk A, Olsson A, Leanderson T. Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer. The Prostate. 66: 1768-78. PMID 16955399 DOI: 10.1002/Pros.20509  0.573
2006 Garrison JB, Kyprianou N. Doxazosin induces apoptosis of benign and malignant prostate cells via a death receptor-mediated pathway. Cancer Research. 66: 464-72. PMID 16397262 DOI: 10.1158/0008-5472.Can-05-2039  0.603
2005 Keledjian K, Garrison JB, Kyprianou N. Doxazosin inhibits human vascular endothelial cell adhesion, migration, and invasion. Journal of Cellular Biochemistry. 94: 374-88. PMID 15526277 DOI: 10.1002/Jcb.20240  0.566
2004 Shaw YJ, Yang YT, Garrison JB, Kyprianou N, Chen CS. Pharmacological exploitation of the alpha1-adrenoreceptor antagonist doxazosin to develop a novel class of antitumor agents that block intracellular protein kinase B/Akt activation. Journal of Medicinal Chemistry. 47: 4453-62. PMID 15317457 DOI: 10.1021/Jm049752K  0.608
2004 Garrison JB, Kyprianou N. Novel targeting of apoptosis pathways for prostate cancer therapy. Current Cancer Drug Targets. 4: 85-95. PMID 14965270 DOI: 10.2174/1568009043481623  0.641
Show low-probability matches.